ANI Pharmaceuticals, Inc.
DE ˙ DB ˙ US00182C1036
54,50 € 0,00 (0,00%)
2023-08-21
CENA AKCJI
SecurityDE:BSFA / ANI Pharmaceuticals, Inc.
InstitutionFifth Third Bancorp
Latest Disclosed Ownership9,372 shares
Latest Disclosed Value $ 720,690
Fifth Third Bancorp reports 17,255.56% increase in ownership of BSFA / ANI Pharmaceuticals, Inc.

On May 1, 2026 - Fifth Third Bancorp filed a 13F-HR form disclosing ownership of 9,372 shares of ANI Pharmaceuticals, Inc. (DE:BSFA) valued at $720,690 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 54 shares of ANI Pharmaceuticals, Inc.. This represents a change in shares of 17,255.56% during the quarter. The current value of the position is $510,774 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-01 2026-03-31 13F ANI PHARMACEUTICALS COM 00182C103 9,372 9,318 17,255.56 721 17,900.00 0.0013
2026-02-02 2025-12-31 13F ANI PHARMACEUTICALS COM 00182C103 54 -3 -5.26 4 -20.00 0.0000
2025-11-07 2025-09-30 13F ANI PHARMACEUTICALS COM 00182C103 57 32 128.00 5 400.00 0.0000
2025-07-15 2025-06-30 13F ANI PHARMACEUTICALS COM 00182C103 25 10 66.67 2 0.00 0.0000
2025-04-15 2025-03-31 13F ANI PHARMACEUTICALS COM 00182C103 15 15 1 0.0000
2025-01-21 2024-12-31 13F ANI PHARMACEUTICALS COM 00182C103 0 -12 -100.00 0 0.0000
2024-10-17 2024-09-30 13F ANI PHARMACEUTICALS COM 00182C103 12 12 1 0.0000
2024-07-22 2024-06-30 13F ANI PHARMACEUTICALS COM 00182C103 0 -2 -100.00 0 0.0000
2024-04-23 2024-03-31 13F ANI PHARMACEUTICALS COM 00182C103 2 2 0 0.0000
2022-08-04 2022-06-30 13F ANI PHARMACEUTICALS COM 00182C103 0 -4 -100.00 0 0.0000
2022-04-19 2022-03-31 13F ANI PHARMACEUTICALS COM 00182C103 4 -78 -95.12 0 -100.00
2022-02-01 2021-12-31 13F ANI PHARMACEUTICALS COM 00182C103 82 78 1,950.00 4 0.0000
2021-10-15 2021-09-30 13F ANI PHARMACEUTICALS COM 00182C103 4 -96 -96.00 0 -100.00
2021-08-06 2021-06-30 13F ANI PHARMACEUTICALS COM 00182C103 100 100 4 0.0000
2020-05-05 2020-03-31 13F ANI PHARMACEUTICALS COM 00182C103 0 -5,832 -100.00 0 -100.00
2020-02-14 2019-12-31 13F ANI PHARMACEUTICALS COM 00182C103 5,832 1,020 21.20 360 2.56 0.0020
2019-11-14 2019-09-30 13F ANI PHARMACEUTICALS COM 00182C103 4,812 -133 -2.69 351 -13.55 0.0021
2019-08-07 2019-06-30 13F ANI PHARMACEUTICALS COM 00182C103 4,945 -1,550 -23.86 406 -11.35 0.0025
2019-05-14 2019-03-31 13F ANI PHARMACEUTICALS COM 00182C103 6,495 -807 -11.05 458 39.21 0.0029
2019-02-14 2018-12-31 13F ANI PHARMACEUTICALS COM 00182C103 7,302 -2,648 -26.61 329 -41.56 0.0024
2018-11-14 2018-09-30 13F ANI PHARMACEUTICALS COM 00182C103 9,950 172 1.76 563 -13.78 0.0036
2018-08-14 2018-06-30 13F ANI PHARMACEUTICALS COM 00182C103 9,778 -454 -4.44 653 9.56 0.0044
2018-05-15 2018-03-31 13F ANI PHARMACEUTICALS COM 00182C103 10,232 1,559 17.98 596 6.62 0.0041
2018-02-14 2017-12-31 13F ANI PHARMACEUTICALS COM 00182C103 8,673 -574 -6.21 559 15.26 0.0038
2017-11-14 2017-09-30 13F ANI PHARMACEUTICALS COM 00182C103 9,247 -233 -2.46 485 9.23 0.0035
2017-08-11 2017-06-30 13F ANI PHARMACEUTICALS COM 00182C103 9,480 -1,370 -12.63 444 -17.32 0.0033
2017-05-12 2017-03-31 13F ANI PHARMACEUTICALS COM 00182C103 10,850 2,424 28.77 537 5.09 0.0041
2017-02-13 2016-12-31 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 8,426 -648 -7.14 511 -15.12 0.0041
2017-02-09 2016-12-31 13F ANI PHARMACEUTICALS COM 00182C103 9,074 0 602 0.0050
2016-11-10 2016-09-30 13F ANI PHARMACEUTICALS COM 00182C103 9,074 9,074 602 0.0050
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.